Vector-borne diseases (VBDs) represent a significant challenge to public health in India. The country's vast geographical diversity and climatic variations create an environment conducive to the spread of various vectors, leading to a high disease burden.
India is currently grappling with a multitude of VBDs including malaria, dengue, chikungunya, and Japanese encephalitis. Malaria alone accounts for a significant portion of the disease burden, with the World Health Organisation estimating around 6.7 million cases in 2018. Additionally, the increasing incidence of dengue and chikungunya pose a substantial threat to public health.
The fight against VBDs in India is fraught with challenges. These include the lack of effective vector control strategies, inadequate healthcare infrastructure, and gaps in disease surveillance. Additionally, the effects of climate change, urbanisation, and population mobility further exacerbate the situation.
Effective control of VBDs necessitates a multi-pronged approach. This includes strengthening surveillance systems, improving diagnostic capabilities, and implementing effective vector control strategies. In addition, increasing community awareness and participation, and fostering intersectoral coordination are crucial. The recent launch of the National Vector Borne Disease Control Programme (NVBDCP) is a step in the right direction, aiming to reduce the morbidity and mortality associated with VBDs.
Vector-borne diseases pose a significant public health challenge in India. While the situation is daunting, a concerted effort involving the government, healthcare professionals, and the community can make a significant difference. By strengthening healthcare infrastructure, improving surveillance, and implementing effective control strategies, India can turn the tide against these diseases. The battle is far from over, but with a comprehensive and coordinated approach, victory is within reach.
1.
Toward rapid and comprehensive genetic diagnosis of pediatric cancer through adaptive sequencing
2.
Q&A: Why adolescents and young adults with cancer are falling behind
3.
Fixed-Duration Combo Shows Promise for Relapsed MCL
4.
Hospital receives 300 backpacks designed to help kids get leukemia treatment on the go
5.
A study has developed molecular markers that predict meningioma recurrence.
1.
Ultimate Guide to Oncology Services in the USA
2.
Exploring the Benefits of Teclistamab for Treating Advanced Cancer
3.
Glofitamab: A Breakthrough Therapy for Relapsed/Refractory Mantle Cell Lymphoma
4.
The Importance of Iron Rich Foods in Preventing and Treating Anemia
5.
Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes
1.
International Cancer Conference
2.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology (ASAHO)
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Updates on the First Line Management of ALK+ NSCLC
2.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Optimizing Treatment Options in Advanced Urothelial Carcinoma
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part II
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation